The How and Why of Bispecific Antibodies for R/R DLBCL: Best Practices for Exemplary Care

Gain in-depth knowledge on bispecific antibodies for the management of relapsed/refractory diffuse large B-cell lymphoma, including guideline-informed treatment and expert-informed recommendations to manage treatment-related side effects, through a ClinicalThought commentary and a downloadable self-study slideset.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Clinical Care Options, LLC

Supporters

Supported by an educational grant from Genmab US, Inc.

Genmab US, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner